Sinalização intracelular e expressão de receptores mediados por LDL modificada e peptídeos da apolipoproteínaB-100 em monócitos/macrófagos humanos. / Intracellular signaling and receptor expression mediated by modified LDL and apolipoproteinB-100 peptides in human monocytes/macrophages.

AUTOR(ES)
DATA DE PUBLICAÇÃO

2009

RESUMO

The Low Density Lipoprotein (LDL) may undergo oxidative or enzymatic modifications, producing lipid or proteic compounds that interact with macrophages, contributing to inflammatory response in the atherosclerosis. Into the arterial intima, the macrophages interact with minimally modified LDL (LoxLDL) and with highly oxidized LDL (HoxLDL). Moreover, in the arterial intima, enzymes may induce cleavage of the apoB-100, releasing protein fragments, which may have biological effects on macrophages. In this study, we showed that modified forms of LDL interact with monocytes or macrophages, depending on oxidation degree. The expression of FcgRII-induced HoxLDL in macrophages is dependent on PPARg and part of the expression of CD36 induced by LoxLDL and HoxLDL in macrophages is dependent on PAF-R. In macrophages, LoxLDL induced higher production of IL-6 e IL-8, whereas HoxLDL induced TNF-a, IL-10 e TGF-b. Furthermore, we found one peptide from apoB-100 capable to increase calcium flux and activate MAP kinase pathway, inducing production of IL-8 in human monocytes.

ASSUNTO(S)

arteriosclerose imunologia monocytes polypeptides monócitos receptor cd36 atherosclerosis fator de ativação de plaquetas polipeptídeos oxidate ldl cd36 receptor macrophages macrófagos immunology cell interaction interação celular ldl oxidata factor activation of platelets

Documentos Relacionados